Activation of HIV-1 Gag-specific CD8+ T cells by yeast-derived VLP-pulsed dendritic cells is influenced by the level of mannose on the VLP antigen

Microbes and Infection

Volumn 11, Issue 2, 2009, Pages 191-197

  Mizukoshi, Fuminori ^a   Yamamoto, Takuya ^a   Mitsuki, Yu ya ^a   Terahara, Kazutaka ^a   Kawana Tachikawa, Ai ^b   Kobayashi, Kazuo ^a   Iwamoto, Aikichi ^b   Morikawa, Yuko ^c   Tsunetsugu Yokota, Yasuko ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

AIDS; Antigen presentation; Mannosylation

Indexed keywords

ANTIGEN; GAG PROTEIN; LECTIN RECEPTOR; MANNOSE; MONOKINE; VIRUS ANTIGEN;

ANTIGEN PRESENTING CELL; ARTICLE; CD8+ T LYMPHOCYTE; CROSS PRESENTATION; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNOGENICITY; INTRACELLULAR TRANSPORT; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; VIRUS LIKE AGENT; YEAST;

CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV-1; HUMANS; MANNOSE; SACCHAROMYCES CEREVISIAE; VIROSOMES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 61449089129     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2008.11.004     Document Type: Article

References (28)

1. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
2. Banchereau J., and Palucka A.K. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 5 (2005) 296-306
3. Figdor C.G., de Vries I.J., Lesterhuis W.J., and Melief C.J. Dendritic cell immunotherapy: mapping the way. Nat. Med. 10 (2004) 475-480
4. Thompson A.G., and Thomas R. Induction of immune tolerance by dendritic cells: implications for preventative and therapeutic immunotherapy of autoimmune disease. Immunol. Cell Biol. 80 (2002) 509-519
5. Ichim T.E., Zhong R., and Min W.P. Prevention of allograft rejection by in vitro generated tolerogenic dendritic cells. Transpl. Immunol. 11 (2003) 295-306
6. Matsue H., Kusuhara M., Matsue K., and Takashima A. Dendritic cell-based immunoregulatory strategies. Int. Arch. Allergy Immunol. 127 (2002) 251-258
7. Colino J., and Snapper C.M. Dendritic cells, new tools for vaccination. Microbes Infect 5 (2003) 311-319
8. Lu W., Arraes L.C., Ferreira W.T., and Andrieu J.M. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nat. Med. 10 (2004) 1359-1365
9. Lu W., Wu X., Lu Y., Guo W., and Andrieu J.M. Therapeutic dendritic-cell vaccine for simian AIDS. Nat. Med. 9 (2003) 27-32
10. Pomerantz R.J., and Horn D.L. Twenty years of therapy for HIV-1 infection. Nat. Med. 9 (2003) 867-873
11. Finzi D., Blankson J., Siliciano J.D., Margolick J.B., Chadwick K., Pierson T., Smith K., Lisziewicz J., Lori F., Flexner C., Quinn T.C., Chaisson R.E., Rosenberg E., Walker B., Gange S., Gallant J., and Siliciano R.F. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5 (1999) 512-517
12. Walker B.D., and Korber B.T. Immune control of HIV: the obstacles of HLA and viral diversity. Nat. Immunol. 2 (2001) 473-475
13. Duerr A., Wasserheit J.N., and Corey L. HIV vaccines: new frontiers in vaccine development. Clin. Infect. Dis. 43 (2006) 500-511
14. Tsunetsugu-Yokota Y., Morikawa Y., Isogai M., Kawana-Tachikawa A., Odawara T., Nakamura T., Grassi F., Autran B., and Iwamoto A. Yeast-derived human immunodeficiency virus type 1 p55(gag) virus-like particles activate dendritic cells (DCs) and induce perforin expression in Gag-specific CD8(+) T cells by cross-presentation of DCs. J. Virol. 77 (2003) 10250-10259
15. Engering A.J., Cella M., Fluitsma D., Brockhaus M., Hoefsmit E.C., Lanzavecchia A., and Pieters J. The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur. J. Immunol. 27 (1997) 2417-2425
16. Tan M.C., Mommaas A.M., Drijfhout J.W., Jordens R., Onderwater J.J., Verwoerd D., Mulder A.A., van der Heiden A.N., Scheidegger D., Oomen L.C., Ottenhoff T.H., Tulp A., Neefjes J.J., and Koning F. Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur. J. Immunol. 27 (1997) 2426-2435
17. Caparros E., Munoz P., Sierra-Filardi E., Serrano-Gomez D., Puig-Kroger A., Rodriguez-Fernandez J.L., Mellado M., Sancho J., Zubiaur M., and Corbi A.L. DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production. Blood 107 (2006) 3950-3958
18. Geijtenbeek T.B., Van Vliet S.J., Koppel E.A., Sanchez-Hernandez M., Vandenbroucke-Grauls C.M., Appelmelk B., and Van Kooyk Y. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197 (2003) 7-17
19. Gringhuis S.I., den Dunnen J., Litjens M., van Het Hof B., van Kooyk Y., and Geijtenbeek T.B. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity 26 (2007) 605-616
20. Kawana-Tachikawa A., Tomizawa M., Nunoya J., Shioda T., Kato A., Nakayama E.E., Nakamura T., Nagai Y., and Iwamoto A. An efficient and versatile mammalian viral vector system for major histocompatibility complex class I/peptide complexes. J. Virol. 76 (2002) 11982-11988
21. Sakuragi S., Goto T., Sano K., and Morikawa Y. HIV type 1 Gag virus-like particle budding from spheroplasts of Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 99 (2002) 7956-7961
22. Ballou C.E. Isolation, characterization, and properties of Saccharomyces cerevisiae mnn mutants with nonconditional protein glycosylation defects. Methods Enzymol 185 (1990) 440-470
23. Morikawa Y., Hinata S., Tomoda H., Goto T., Nakai M., Aizawa C., Tanaka H., and Omura S. Complete inhibition of human immunodeficiency virus Gag myristoylation is necessary for inhibition of particle budding. J. Biol. Chem. 271 (1996) 2868-2873
24. Tsunetsugu-Yokota Y., Akagawa K., Kimoto H., Suzuki K., Iwasaki M., Yasuda S., Hausser G., Hultgren C., Meyerhans A., and Takemori T. Monocyte-derived cultured dendritic cells are susceptible to human immunodeficiency virus infection and transmit virus to resting T cells in the process of nominal antigen presentation. J. Virol. 69 (1995) 4544-4547
25. Ballou C.E. Yeast cell wall and cell surface. In: Stranthern J.N., Jones E.W., and Broach J.R. (Eds). The Molecular Biology of the Yeast Saccharomyces. Metabolism and Gene Expression (1982), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 335-360
26. Christinck E.R., Luscher M.A., Barber B.H., and Williams D.B. Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature 352 (1991) 67-70
27. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 8 (2003) 223-246
28. Nigou J., Zelle-Rieser C., Gilleron M., Thurnher M., and Puzo G. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J. Immunol. 166 (2001) 7477-7485